The present disclosure discloses a crystalline hydrated form of about 2-3 molecules of water afatinib zimareate, designated Form Z, a pharmaceutical composition comprising the same, a method for its use to treat a patient. , And methods for its preparation. [Selection diagram] Figure 1
展开▼